ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Study of WAL0921 in Patients With Glomerular Kidney Diseases

ClinicalTrials.gov ID: NCT06466135

Public ClinicalTrials.gov record NCT06466135. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 10:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of WAL0921 in Patients With Glomerular Kidney Diseases and Proteinuria

Study identification

NCT ID
NCT06466135
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Walden Biosciences
Industry
Enrollment
96 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 1, 2024
Primary completion
Feb 28, 2027
Completion
May 31, 2027
Last update posted
Apr 1, 2026

2024 – 2027

United States locations

U.S. sites
9
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
Academic Medical Research Institute Los Angeles California 90022 Recruiting
Colorado Kidney and Vascular Care Denver Colorado 80012 Recruiting
D & H Tamarac Research Center Tamarac Florida 33321 Recruiting
Fides Clinical Research Atlanta Georgia 30342 Recruiting
Nephrology Associates of Northern Illinois and Indiana (NANI) Hinsdale Illinois 60521 Recruiting
Dunes Clinical Research Dakota Dunes South Dakota 57049 Recruiting
Prolato Clinical Research Center Houston Texas 77054 Recruiting
Clinical Trial Network Houston Texas 77074 Recruiting
Clinical Advancement Center San Antonio Texas 78212 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06466135, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 1, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06466135 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →